BIO-TECHNE CORP (TECH) Stock Analyst Ratings
NASDAQ:TECH • US09073M1045
56.99 USD
-0.83 (-1.44%)
At close: Mar 3, 2026
56.99 USD
0 (0%)
After Hours: 3/3/2026, 6:46:55 PM
ChartMill assigns a Buy % Consensus number of 82% to TECH. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 76.73. This target is 34.63% above the current price.
- TECH was analyzed by 23 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about TECH.
- In the previous month the buy percentage consensus was at a similar level.
- TECH was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-05 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-05 | UBS | Maintains | Buy -> Buy |
| 2026-02-05 | Stifel | Maintains | Hold -> Hold |
| 2026-02-05 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-05 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-05 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-11-20 | Argus Research | Maintains | Buy -> Buy |
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-14 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-03 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2025-08-21 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-07-11 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-07-09 | TD Cowen | Initiate | Buy |
| 2025-06-05 | Benchmark | Reiterate | Buy -> Buy |
| 2025-05-30 | Wells Fargo | Initiate | Overweight |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-05-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-05-08 | Stifel | Maintains | Hold -> Hold |
| 2025-04-09 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-04-08 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-03-18 | Evercore ISI Group | Initiate | Outperform |
| 2025-03-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-02-19 | Baird | Downgrade | Outperform -> Neutral |
| 2025-02-06 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-06 | Keybanc | Maintains | Overweight -> Overweight |
BIO-TECHNE CORP / TECH FAQ
What do analysts expect the price target to be for BIO-TECHNE CORP (TECH)?
23 analysts have analysed TECH and the average price target is 76.73 USD. This implies a price increase of 34.63% is expected in the next year compared to the current price of 56.99.
What is the consensus rating for BIO-TECHNE CORP (TECH) stock?
The consensus rating for BIO-TECHNE CORP (TECH) is 81.7391 / 100 . This indicates that analysts generally have a positive outlook on the stock.